Wednesday, 2 January 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
January
(48)
- Prosonix licenses Rafael ultrasound technology
- SAFC is adding a $600,000 second-phase expansion t...
- Eden Biodesign will develop iQur’s ‘tandem core’ v...
- NPIL adds high potency suite
- Johnson Matthey's fine chemicals division saw incr...
- Scots showcase at Informex
- Codexis launches metabolite tool
- Rhodium catalysts could improve pharmaceutical man...
- 13 years for FDA
- Up and down for Albemarle
- Shasun establishes US facility
- Scientific Protein Laboratories will produce Oncon...
- FDA confirms overseas plans
- Peptisyntha will supply peptides for Helix BioMedix
- Dishman looks for growth and Euro acquisition
- Cobra Biomanufacturing will manufacture GenVec's a...
- Krebs will manufacture L-cysteine for Wacker Chemie
- Codexis goes east
- Novasep has increased its high potency API capacit...
- Lonza will produce cell cultured vaccines for Sano...
- Lonza profits up, acquisitions possible
- Angel Biotechnology is granted manufacturer's and ...
- Ian Shott discusses his vision behind Excelsyn
- Extinction for drugs
- Nicholas Piramal has purchased an injectables manu...
- FDA's passage to India
- Another Pfizer sale
- NPIL saw custom manufacturing sales grow 7.2% to R...
- BASF appoints Ruchatz
- Cobra slithers into the red
- Codexis goes Green
- EC investigates big pharma
- More outsourcing expected
- FDA to send staff overseas
- SAFC invests in biologics
- Investors shun pharma
- Celltrion will development and manufacture CSL's C...
- Euro pharma squeezed
- AMRI expects to further expand its workforce durin...
- Saltigo goes west
- Teva invests
- Peakdale Molecular has completed a £1m round of eq...
- Cambrex Karlskoga will acquire ProSyntest AS for a...
- Hikal has signed a long-term manufacturing deal wi...
- Marketing spend double R&D
- Fewer approvals
- Akzo Nobel has completed its takeover of ICI
- Big Pharma sells - part two
-
▼
January
(48)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment